Cellebrite DI Ltd. cash flow statement

In fiscal 2025, Cellebrite DI Ltd.'s operations generated $174m of cash; it spent $13.2m on capital projects, leaving free cash flow of $160m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cellebrite DI Ltd.: cash flow statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	16	67	36	21	102	132	174
Depreciation and amortisation	4	6	7	9	10	11	12
Stock-based pay	13	7	6	14	19	31	45
Capital spending	6	6	5	7	5	9	13
Free cash flow	10	60	31	14	97	124	160
Free cash flow after stock pay	−3	53	24	−0	78	93	115
Dividends paid	25	10	100	0	0	—	—
Share buybacks	1	0	0	0	—	—	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ADEA vs CLBT CLBT vs SPT AVPT vs CLBT

More: Application Software stocks compared, Technology sector, rankings of US companies

Figures from Cellebrite DI Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Cellebrite DI Ltd.